United Therapeutics (UTHR) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
United Therapeutics · Health Care · ref. ETF XLV · 84 calls · price $543.4
What the company does: United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
📈 United Therapeutics (UTHR) stock price
$543.4+25.3% over range
Oct 14, 25low $415.34 · high $596.76Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
57% recommend buying · 7 analysts
📊 JPI status : United Therapeutics has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 UTHR price target & analyst consensus — price $543
The price target · all analysts combined (7 targets)
Highest target · 1 firm of 7$738+35.8%
Median target · of 7 targets$687+26.4%
Lowest target · 1 firm of 7$321-40.9%
Current price$543.4
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
686%
$566 ↔ $738
Below
114%
$321
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: BTIG — 63% of its targets hit on this sector (41 calls tested). It aims for $728 (+34 %), call made on October 2, 2026, maturing on October 2, 2027 (12 d ago).
The 4 reliable analysts
$698+28 %
The 3 other firms
$613+13 %
How to read it: the 4 reliable firms are not filtered by optimism — 3 aim above the price, 1 below, hence their $698 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy457%
Hold229%
Sell114%
Strong Sell00%
Go deeper on the analysts
🎯 UTHR price target all
All 84 calls, one by one, with our verdict on each firm.
→ See all 84 targets, analyst by analyst💡 The best analysts on UTHR most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in UTHR? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about United Therapeutics? The JPI assistant answers using our backtest data.
📈 United Therapeutics fundamentals: valuation, margins & growth › open the full page
P/E 19.5Net margin 41.6 %Revenue growth -1.9 %Fairly valued
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 38 %
2023
Rev +20%Profit +35%
2024
Rev +24%Profit +21%
2025
Rev +11%Profit +12%
🏛️ United Therapeutics insider buying: who's buying and how much › open the full page
1 insider bought1 buys / 6 mo $864k
🔎 Detailed analyses
✅ Historical analyst reliability on UTHR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Cantor Fitzgerald ↗ | 100% | +48.3% | 2 |
| Ladenburg Thalmann ↗ | 100% | +29.1% | 8 |
| Standpoint Research | 80% | +34.8% | 5 |
| Jefferies ↗ | 80% | +24.6% | 5 |
| UBS ↗ | 78% | +27.3% | 9 |
| Credit Suisse | 73% | +28.4% | 11 |
| Wedbush ↗ | 70% | +26.1% | 10 |
| Wells Fargo ↗ | 67% | +7.2% | 3 |
| Oppenheimer ↗ | 62% | +12.4% | 8 |
| HC Wainwright & Co. ↗ | 60% | +24.6% | 15 |
See the other 6 firms
| Goldman Sachs ↗ | 33% | -25.1% | 3 |
| TD Cowen ↗ | 50% | +2.6% | 2 |
| Barclays ↗ | 50% | +3.1% | 4 |
| Morgan Stanley ↗ | 57% | +12.1% | 7 |
| JP Morgan ↗ | 58% | +27.4% | 12 |
| Argus Research ↗ | 60% | +1.5% | 5 |
📊 What $1,000 invested in United Therapeutics would be worth › open the full page
In short — $1,000 invested in United Therapeutics 10 years ago would be worth $3,460 today, i.e. +13%/yr on average. Best year: 2020 (+72%), worst: 2018 (-26%). Price performance, excluding dividends.
If I'd invested $1,000 in United Therapeutics
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,536 | +54% |
| 3 years ago | $1,948 | +95% |
| 5 years ago | $3,570 | +257% |
Return by year (United Therapeutics)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +11% | $1,112 (+11%) |
| 2025 | +38% | $1,536 (+54%) |
| 2024 | +60% | $2,464 (+146%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on United Therapeutics
Loading news…
📋 All analyst calls on UTHR
Filtered on — · ✕ show all
RBC Capital ↗
Oct 8, 26
▲ Outperform · 🎯$708
Price at call : $549.16 — upside +29%
Today : $543.4 — upside +30%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Oct 8, 27
matures : Oct 8, 27
Morgan Stanley ↗
Oct 7, 26
■ Equal-Weight neutral · not a buy · 🎯$566
Price at call : $532.78 — gap to target +6%
Today : $543.4 — gap to target +4%
🎯 on UTHR : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
▲ Buy · 🎯$728
Price at call : $571.38 — upside +27%
Today : $543.4 — upside +34%
🎯 on UTHR : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Oct 1, 27
matures : Oct 1, 27
Goldman Sachs ↗
Sep 24, 26
▼ Sell · 🎯$321
Price at call : $475.45 — upside -32%
Today : $543.4 — upside -41%
🎯 on UTHR : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Sep 24, 27
matures : Sep 24, 27
RBC Capital ↗
Aug 6, 26
▲ Outperform · 🎯$677
Price at call : $538.84 — upside +26%
Today : $543.4 — upside +25%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Overweight · 🎯$687
Price at call : $528.47 — upside +30%
Today : $543.4 — upside +26%
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
B of A Securities ↗
Jul 10, 26
■ Neutral neutral · not a buy · 🎯$613
Price at call : $535.57 — gap to target +14%
Today : $543.4 — gap to target +13%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Jul 10, 27
matures : Jul 10, 27
RBC Capital ↗
Jul 7, 26
▲ Outperform · 🎯$704
Price at call : $554.34 — upside +27%
Today : $543.4 — upside +30%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
See the other 76 calls, newest to oldest
RBC Capital ↗
May 7, 26
▲ Outperform · 🎯$701
Price at call : $564.94 — upside +24%
Today : $543.4 — upside +29%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Wells Fargo ↗
May 7, 26
▲ Overweight · 🎯$738
Price at call : $564.94 — upside +31%
Today : $543.4 — upside +36%
🎯 on UTHR : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Morgan Stanley ↗
Apr 10, 26
■ Equal-Weight neutral · not a buy · 🎯$519
Price at call : $577.63 — gap to target -10%
Today : $543.4 — gap to target -4%
🎯 on UTHR : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Apr 10, 27
matures : Apr 10, 27
HC Wainwright & Co. ↗
Mar 31, 26
▲ Buy · 🎯$660
Price at call : $570.27 — upside +16%
Today : $543.4 — upside +21%
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Mar 31, 27
matures : Mar 31, 27
Wells Fargo ↗
Mar 31, 26
■ Equal-Weight neutral · not a buy · 🎯$575
Price at call : $570.27 — gap to target +1%
Today : $543.4 — gap to target +6%
🎯 on UTHR : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Mar 31, 27
matures : Mar 31, 27
B of A Securities ↗
Mar 31, 26
■ Neutral neutral · not a buy · 🎯$626
Price at call : $592.98 — gap to target +6%
Today : $543.4 — gap to target +15%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Mar 31, 27
matures : Mar 31, 27
▲ Buy · 🎯$660
Price at call : $592.98 — upside +11%
Today : $543.4 — upside +21%
🎯 on UTHR : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Mar 30, 27
matures : Mar 30, 27
Wells Fargo ↗
Mar 23, 26
■ Equal-Weight neutral · not a buy · 🎯$486
Price at call : $521.22 — gap to target -7%
Today : $543.4 — gap to target -11%
🎯 on UTHR : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Mar 23, 27
matures : Mar 23, 27
Cantor Fitzgerald ↗
Mar 12, 26
▲ Overweight · 🎯$625
Price at call : $536.12 — upside +17%
Today : $543.4 — upside +15%
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
in progress (365j)
matures : Mar 12, 27
matures : Mar 12, 27
▲ Buy · 🎯$705
Price at call : $478.16 — upside +47%
Today : $543.4 — upside +30%
🎯 on UTHR : 100% (4 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
HC Wainwright & Co. ↗
Feb 26, 26
▲ Buy · 🎯$600
Price at call : $503.9 — upside +19%
Today : $543.4 — upside +10%
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$575
Price at call : $503.9 — upside +14%
Today : $543.4 — upside +6%
🎯 on UTHR : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Oppenheimer ↗
Feb 26, 26
▲ Outperform · 🎯$600
Price at call : $503.9 — upside +19%
Today : $543.4 — upside +10%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 54.3% · +4.5% (70 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
RBC Capital ↗
Feb 26, 26
▲ Outperform · 🎯$643
Price at call : $503.9 — upside +28%
Today : $543.4 — upside +18%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Wells Fargo ↗
Feb 26, 26
■ Equal-Weight neutral · not a buy · 🎯$466
Price at call : $503.9 — gap to target -8%
Today : $543.4 — gap to target -14%
🎯 on UTHR : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$645
Price at call : $503.69 — upside +28%
Today : $543.4 — upside +19%
🎯 on UTHR : 100% (4 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Jan 6, 27
matures : Jan 6, 27
▲ Buy · 🎯$600
Price at call : $448.91 — upside +34%
Today : $543.4 — upside +10%
🎯 on UTHR : 100% (4 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
HC Wainwright & Co. ↗
Oct 30, 25
▲ Buy · 🎯$525
Price at call : $445.43 — upside +18%
Today : $543.4 — upside -3%
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
RBC Capital ↗
Oct 30, 25
▲ Outperform · 🎯$587
Price at call : $445.43 — upside +32%
Today : $543.4 — upside +8%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
Wells Fargo ↗
Oct 30, 25
■ Equal-Weight neutral · not a buy · 🎯$423
Price at call : $445.43 — gap to target -5%
Today : $543.4 — gap to target -22%
🎯 on UTHR : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
Morgan Stanley ↗
Oct 10, 25
■ Equal-Weight neutral · not a buy · 🎯$435
Price at call : $440.06 — gap to target -1%
Today : $543.4 — gap to target -20%
🎯 on UTHR : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Oct 10, 26
matures : Oct 10, 26
▲ Buy · 🎯$580
Price at call : $419.21 — upside +38%
Today : $543.4 — upside +7%
Expected +38% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (4 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
+29.3%
stock +29% · XLV +21%
matured Sep 29, 26
RBC Capital ↗
Sep 26, 25
▲ Outperform · 🎯$569
Price at call : $432.66 — upside +32%
Today : $543.4 — upside +5%
Expected +32% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 48.8% · +6.8% (201 calls)
+12.2%
stock +12% · XLV +26%
matured Sep 26, 26
Cantor Fitzgerald ↗
Sep 10, 25
▲ Overweight · 🎯$525
Price at call : $396.5 — upside +32%
Today : $543.4 — upside -3%
Expected +32% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+27.1%
stock +27% · XLV +21%
matured Sep 10, 26
Oppenheimer ↗
Sep 5, 25
▲ Outperform · 🎯$575
Price at call : $394.62 — upside +46%
Today : $543.4 — upside +6%
Expected +46% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 54.3% · +4.5% (70 calls)
+26.2%
stock +26% · XLV +21%
matured Sep 5, 26
HC Wainwright & Co. ↗
Sep 5, 25
▲ Buy · 🎯$500
Price at call : $400.52 — upside +25%
Today : $543.4 — upside -8%
Expected +25% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+24.3%
stock +24% · XLV +21%
matured Sep 5, 26
▲ Buy · 🎯$560
Price at call : $380.47 — upside +47%
Today : $543.4 — upside +3%
Expected +47% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (4 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
+28.2%
stock +28% · XLV +25%
matured Sep 4, 26
Wells Fargo ↗
Sep 3, 25
■ Equal-Weight neutral · not a buy · 🎯$414
Price at call : $391.45 — gap to target +6%
Today : $543.4 — gap to target -24%
🎯 on UTHR : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Sep 3, 26
matures : Sep 3, 26
▲ Buy · 🎯$564
Price at call : $391.45 — upside +44%
Today : $543.4 — upside +4%
Expected +44% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 48.3% · +10.7% (116 calls)
+25.2%
stock +25% · XLV +27%
matured Sep 2, 26
B of A Securities ↗
Sep 2, 25
■ Neutral neutral · not a buy · 🎯$463
Price at call : $391.45 — gap to target +18%
Today : $543.4 — gap to target -15%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Sep 2, 26
matures : Sep 2, 26
▲ Buy · 🎯$415
Price at call : $309.72 — upside +34%
Today : $543.4 — upside -24%
Expected +34% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (4 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
+61.9%
stock +62% · XLV +26%
matured Aug 13, 26
Wells Fargo ↗
Jul 31, 25
■ Equal-Weight neutral · not a buy · 🎯$295
Price at call : $294.28 — gap to target +0%
Today : $543.4 — gap to target -46%
🎯 on UTHR : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Jul 31, 26
matures : Jul 31, 26
HC Wainwright & Co. ↗
Jul 31, 25
▲ Buy · 🎯$400
Price at call : $274.7 — upside +46%
Today : $543.4 — upside -26%
Expected +46% · Actual +88% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+88.5%
stock +88% · XLV +25%
matured Jul 31, 26
Morgan Stanley ↗
Jul 10, 25
■ Equal-Weight neutral · not a buy · 🎯$328
Price at call : $295.52 — gap to target +11%
Today : $543.4 — gap to target -40%
🎯 on UTHR : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Jul 10, 26
matures : Jul 10, 26
▲ Overweight · 🎯$330
Price at call : $300.56 — upside +10%
Today : $543.4 — upside -39%
Expected +10% · Actual +84% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49% · +7.1% (147 calls)
+83.8%
stock +84% · XLV +20%
matured Jul 8, 26
▲ Buy · 🎯$385
Price at call : $290.91 — upside +32%
Today : $543.4 — upside -29%
Expected +32% · Actual +88% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (4 calls matureds) · 📊 on Health : 49.2% · +16.9% (124 calls)
+88.1%
stock +88% · XLV +17%
matured Jun 30, 26
B of A Securities ↗
Jun 11, 25
■ Neutral neutral · not a buy · 🎯$315
Price at call : $286.14 — gap to target +10%
Today : $543.4 — gap to target -42%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Jun 11, 26
matures : Jun 11, 26
Cantor Fitzgerald ↗
Jun 2, 25
▲ Overweight · 🎯$405
Price at call : $324.2 — upside +25%
Today : $543.4 — upside -25%
Expected +25% · Actual +69% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+69.5%
stock +69% · XLV +11%
matured Jun 2, 26
HC Wainwright & Co. ↗
May 5, 25
▲ Buy · 🎯$425
Price at call : $298.7 — upside +42%
Today : $543.4 — upside -22%
Expected +42% · Actual +92% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+91.6%
stock +92% · XLV +5%
matured May 5, 26
▲ Overweight · 🎯$350
Price at call : $294.6 — upside +19%
Today : $543.4 — upside -36%
Expected +19% · Actual +97% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49% · +7.1% (147 calls)
+97.3%
stock +97% · XLV +4%
matured May 1, 26
Morgan Stanley ↗
May 1, 25
■ Equal-Weight neutral · not a buy · 🎯$348
Price at call : $294.6 — gap to target +18%
Today : $543.4 — gap to target -36%
🎯 on UTHR : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : May 1, 26
matures : May 1, 26
B of A Securities ↗
May 1, 25
■ Neutral neutral · not a buy · 🎯$321
Price at call : $293.85 — gap to target +9%
Today : $543.4 — gap to target -41%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : May 1, 26
matures : May 1, 26
HC Wainwright & Co. ↗
Feb 27, 25
▲ Buy · 🎯$425
Price at call : $323.62 — upside +31%
Today : $543.4 — upside -22%
Expected +31% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+55.7%
stock +56% · XLV +9%
matured Feb 27, 26
Ladenburg Thalmann ↗
Oct 31, 24
▲ Buy · 🎯$344
Price at call : $374.02 — upside -8%
Today : $543.4 — upside -37%
Expected -8% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+17.3%
stock +17% · XLV -2%
matured Oct 31, 25
Argus Research ↗
Oct 31, 24
▲ Buy · 🎯$400
Price at call : $374.02 — upside +7%
Today : $543.4 — upside -26%
Expected +7% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
+17.3%
stock +17% · XLV -2%
matured Oct 31, 25
HC Wainwright & Co. ↗
Oct 31, 24
▲ Buy · 🎯$425
Price at call : $374.02 — upside +14%
Today : $543.4 — upside -22%
Expected +14% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+17.3%
stock +17% · XLV -2%
matured Oct 31, 25
HC Wainwright & Co. ↗
Aug 1, 24
▲ Buy · 🎯$400
Price at call : $327.79 — upside +22%
Today : $543.4 — upside -26%
Expected +22% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
-10.2%
stock -10% · XLV -13%
matured Aug 1, 25
HC Wainwright & Co. ↗
Jul 25, 24
▲ Buy · 🎯$400
Price at call : $336.37 — upside +19%
Today : $543.4 — upside -26%
Expected +19% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
-9.5%
stock -9% · XLV -8%
matured Jul 25, 25
HC Wainwright & Co. ↗
May 2, 24
▲ Buy · 🎯$300
Price at call : $258.13 — upside +16%
Today : $543.4 — upside -45%
Expected +16% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+14.1%
stock +14% · XLV -1%
matured May 2, 25
▲ Outperform · 🎯$308
Price at call : $217.6 — upside +42%
Today : $543.4 — upside -43%
Expected +42% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+66.0%
stock +66% · XLV -1%
matured Feb 21, 25
HC Wainwright & Co. ↗
Feb 22, 24
▲ Buy · 🎯$300
Price at call : $217.6 — upside +38%
Today : $543.4 — upside -45%
Expected +38% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+66.0%
stock +66% · XLV -1%
matured Feb 21, 25
Leerink Partners ↗
Feb 5, 24
▲ Outperform · 🎯$330
Price at call : $212.76 — upside +55%
Today : $543.4 — upside -39%
Expected +55% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 58.3% · +20.9% (12 calls)
+66.1%
stock +66% · XLV +3%
matured Feb 4, 25
▲ Outperform · 🎯$308
Price at call : $228.18 — upside +35%
Today : $543.4 — upside -43%
Expected +35% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+63.9%
stock +64% · XLV +17%
matured Nov 1, 24
Ladenburg Thalmann ↗
Aug 3, 23
▲ Buy · 🎯$268
Price at call : $231.87 — upside +16%
Today : $543.4 — upside -51%
Expected +16% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+41.3%
stock +41% · XLV +14%
matured Aug 2, 24
▲ Outperform · 🎯$307
Price at call : $231.87 — upside +32%
Today : $543.4 — upside -44%
Expected +32% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+41.3%
stock +41% · XLV +14%
matured Aug 2, 24
HC Wainwright & Co. ↗
Aug 3, 23
▲ Buy · 🎯$300
Price at call : $231.87 — upside +29%
Today : $543.4 — upside -45%
Expected +29% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+41.3%
stock +41% · XLV +14%
matured Aug 2, 24
Ladenburg Thalmann ↗
May 4, 23
▲ Buy · 🎯$256
Price at call : $215.72 — upside +19%
Today : $543.4 — upside -53%
Expected +19% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+21.6%
stock +22% · XLV +6%
matured May 3, 24
Argus Research ↗
Apr 21, 23
▲ Buy · 🎯$280
Price at call : $230.76 — upside +21%
Today : $543.4 — upside -48%
Expected +21% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
+1.4%
stock +1% · XLV +4%
matured Apr 20, 24
HC Wainwright & Co. ↗
Feb 23, 23
▲ Buy · 🎯$300
Price at call : $248.36 — upside +21%
Today : $543.4 — upside -45%
Expected +21% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
-8.6%
stock -9% · XLV +14%
matured Feb 23, 24
Argus Research ↗
Jan 11, 23
▲ Buy · 🎯$300
Price at call : $263.79 — upside +14%
Today : $543.4 — upside -45%
Expected +14% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
-16.5%
stock -16% · XLV +4%
matured Jan 11, 24
HC Wainwright & Co. ↗
Nov 3, 22
▲ Buy · 🎯$300
Price at call : $265.42 — upside +13%
Today : $543.4 — upside -45%
Expected +13% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 67% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
-15.4%
stock -15% · XLV -2%
matured Nov 3, 23
▲ Outperform · 🎯$263
Price at call : $218.95 — upside +20%
Today : $543.4 — upside -52%
Expected +20% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
-2.2%
stock -2% · XLV -2%
matured May 24, 23
▲ Outperform · 🎯$236
Price at call : $166.2 — upside +42%
Today : $543.4 — upside -57%
Expected +42% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+48.0%
stock +48% · XLV -2%
matured Feb 28, 23
Ladenburg Thalmann ↗
Feb 25, 22
▲ Buy · 🎯$203
Price at call : $166.2 — upside +22%
Today : $543.4 — upside -63%
Expected +22% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+48.6%
stock +49% · XLV -1%
matured Feb 25, 23
Argus Research ↗
Jul 14, 21
▲ Buy · 🎯$205
Price at call : $183.59 — upside +12%
Today : $543.4 — upside -62%
Expected +12% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
+29.2%
stock +29% · XLV -1%
matured Jul 14, 22
▲ Outperform · 🎯$244
Price at call : $113.5 — upside +115%
Today : $543.4 — upside -55%
Expected +115% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+60.3%
stock +60% · XLV +25%
matured Jul 30, 21
Ladenburg Thalmann ↗
Aug 1, 19
▲ Buy · 🎯$106
Price at call : $83.07 — upside +28%
Today : $543.4 — upside -80%
Expected +28% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+34.2%
stock +34% · XLV +16%
matured Jul 31, 20
▲ Outperform · 🎯$273
Price at call : $101.25 — upside +170%
Today : $543.4 — upside -50%
Expected +170% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+7.8%
stock +8% · XLV +9%
matured May 1, 20
▲ Outperform · 🎯$253
Price at call : $123.24 — upside +105%
Today : $543.4 — upside -53%
Expected +105% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
-32.4%
stock -32% · XLV +2%
matured Aug 2, 19
Ladenburg Thalmann ↗
Oct 28, 16
▲ Buy
Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+1.5%
stock +1% · XLV +20%
matured Oct 28, 17
Ladenburg Thalmann ↗
Apr 29, 16
■ Neutral neutral · not a buy
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
in progress (365j)
matures : Apr 29, 17
matures : Apr 29, 17
▲ Outperform · 🎯$244
Price at call : $162.66 — upside +50%
Today : $543.4 — upside -55%
Expected +50% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
-22.0%
stock -22% · XLV +1%
matured Aug 19, 16
Argus Research ↗
Mar 12, 15
▲ Buy
Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
-23.7%
stock -24% · XLV -5%
matured Mar 11, 16
▲ Outperform · 🎯$141
Price at call : $115.22 — upside +22%
Today : $543.4 — upside -74%
Expected +22% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+30.7%
stock +31% · XLV +10%
matured Aug 29, 15
Ladenburg Thalmann ↗
Dec 23, 13
▲ Buy · 🎯$138
Price at call : $112.85 — upside +22%
Today : $543.4 — upside -75%
Expected +22% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+15.4%
stock +15% · XLV +25%
matured Dec 23, 14
Ladenburg Thalmann ↗
Apr 30, 12
▲ Buy · 🎯$58
Price at call : $43.75 — upside +33%
Today : $543.4 — upside -89%
Expected +33% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+52.6%
stock +53% · XLV +26%
matured Apr 30, 13
Frequently asked questions
Should I buy United Therapeutics stock?
This isn't buy advice. For United Therapeutics, the analyst consensus is "Hold", with an average price target of $687 (+26% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on United Therapeutics). We show the numbers — you decide.
Is it too late to buy United Therapeutics? How high can it go?
The most bullish analyst target on United Therapeutics is $738 (+36% above today's price); the average is $687. That's the upside they see. Check how reliable those analysts have actually been on United Therapeutics on our site before trusting it.
Is United Therapeutics still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 16 analysts have a real record on United Therapeutics, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in United Therapeutics? The case for and against
The arguments for and against, one by one, from the numbers: why invest in UTHR (and why hesitate).
What has United Therapeutics's past performance been?
Historical returns and a "how much if I had invested" calculator: UTHR performance & returns.
What is the best month to buy UTHR?
The 12 months ranked by the stock's past returns: best & worst month to buy UTHR.
Are insiders buying UTHR stock?
Executives' and large holders' buys and sells, decoded: insider buying on UTHR.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX